Ginsenoside Rg2 Delays Brain Aging Via Inhibiting Α-Synuclein Expression And Promoting Foxo-Mediated Neurogenesis In Mice
As we age, our brains naturally undergo changes that can affect memory and cognitive abilities. Recent research sheds light on a potential way to combat this decline. Scientists have identified a protein called α-synuclein (alpha-synuclein) as a key “accelerator” of brain aging, which hinders the brain’s ability to generate new cells, a process known as neurogenesis.
However, a natural compound derived from ginseng, called Ginsenoside Rg2, shows promise in counteracting these effects. This compound works by reducing the levels of α-synuclein and actively promoting the creation of new brain cells through a specific pathway involving FoxO1.
In studies conducted on aging mice, treatment with this ginseng compound led to several positive outcomes. Researchers observed a significant decrease in α-synuclein expression, reduced oxidative stress (damage to cells caused by unstable molecules), and fewer markers typically associated with aging. Importantly, there was an increase in neurogenesis and a notable improvement in cognitive function.
These findings not only provide a scientific basis for the traditional use of ginseng in supporting cognitive health but also suggest a potential new therapeutic strategy for addressing age-related cognitive decline.
Source: link to paper